Evidence map›Paper›PMID 41414941›Full record

SynthesisJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2026

National Delphi consensus on laser and energy-based treatments for rosacea.

Lynhda Nguyen, Nikolaus Seeber, Uwe Paasch, Martin Schaller, Claudia Borelli, Syrus Karsai, Gerd Kautz, Tanja C Fischer, Michael Drosner, Stefan Hammes and 7 more

Abstract readConsensus StatementSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Lynhda NguyenDepartment of Laser and Aesthetic, Department of Dermatology and Venereology, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.ORCID https://orcid.org/0000-0002-1258-6390
Nikolaus SeeberJoint Practice for Dermatology Dres. Peter/Seeber/Altheide, Hamburg, Germany.
Uwe PaaschDepartment of Dermatology, Venereology and Allergy, University of Leipzig, Leipzig, Germany.
Martin SchallerDepartment of Dermatology, University Hospital Tübingen, Tübingen, Germany.
Claudia BorelliAesthetic and Laser Unit, Department of Dermatology, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Syrus KarsaiDermatologikum Hamburg, Hamburg, Germany.
Gerd KautzSkin and Laser Clinic Dr. Kautz, Konz, Germany.
Tanja C FischerSkin and Laser Center, Potsdam, Germany.
Michael DrosnerSkin & Laser Schwerin, Schwerin, Germany.
Stefan HammesDepartment for Oral and Maxillofacial Surgery/Plastic Surgery, University of Greifswald, Greifswald, Germany.
Konstantin FeiseSophienklinik, Stuttgart, Germany.
Christian RaulinLaserklinik Karlsruhe GmbH, Karlsruhe, Germany.
Martina KerscherDivision of Cosmetic Sciences, Department of Chemistry, University of Hamburg, Hamburg, Germany.
Gerd GauglitzHaut- und Laserzentrum Glockenbach, Munich, Germany.
Jens M BaronDepartment of Dermatology and Allergology, University Hospital RWTH Aachen, Aachen, Germany.
Stefan W SchneiderDepartment of Dermatology and Venereology, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.
Katharina HerbergerDepartment of Laser and Aesthetic, Department of Dermatology and Venereology, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVarious treatments are available for rosacea, including lasers and energy-based devices (EBDs). However, the specific role of lasers and EBDs in rosacea management remains insufficiently defined in Germany. The aim of the study was to develop a comprehensive expert consensus on the use of lasers and EBDs in the treatment of rosacea. PATIENTS AND

methodsA three-phase study was conducted. First, a steering group performed a systematic literature review and meta-analysis. Second, a prospective, multicenter online survey gathered patient-reported experiences and treatment perspectives. Third, a structured, three-round Delphi process was implemented to discuss consensus statements based on the literature and patient input.

resultsA total of 185 patients participated in the survey. Based on the systematic review and patient questionnaire consensus was performed on (1) the role of lasers and EBDs across different rosacea phenotypes, (2) the integration of laser/EBD treatments with combination therapies, and (3) best practices for pre- and post-treatment care. 16 dermatologists contributed to the Delphi process.

conclusionsThis expert consensus offers practical guidance for incorporating laser and EBD therapies into rosacea treatment strategies. The Delphi process clarifies key aspects of their role in management, their integration into combination therapies and directions for future research.

Indexed as

Laser TherapyRosaceaCombined Modality TherapyDelphi TechniqueGermanyHumansTreatment OutcomeDelphi consensusenergy‐based systemslasersnon‐ionizing beam sourcesrosacea

Identifiers

PMID41414941
PMCPMC13434986

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.